Bliss GVS Pharma Shareholding

Bliss GVS Pharma Ltd Shareholding Pattern

The Bliss GVS Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Bliss GVS Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Bliss GVS Pharma Ltd (NSE: BLISSGVS, BSE: 506197) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Bliss GVS Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Bliss GVS Pharma Ltd Shareholding Pattern (Latest)

The latest Bliss GVS Pharma Ltd shareholding for Dec 2025 is:

• Promoters: 35.36%
• FII: 14.54%
• DII: 5.78%
• Public: 44.32%
• Government: 0%

A slight decline in promoter holding may indicate stake dilution or strategic selling.

Bliss GVS Pharma Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Bliss GVS Pharma Ltd.

• Dec 2025: 35.36%
• Sept 2025: 35.39%
• Jun 2025: 35.44%
• Mar 2025: 35.29%
• Dec 2024: 35.10%

Promoter stake remains largely stable, showing consistent ownership structure.

Bliss GVS Pharma Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Bliss GVS Pharma Ltd.

• Dec 2025: 14.54%
• Sept 2025: 13.27%
• Jun 2025: 12.65%
• Mar 2025: 13.18%
• Dec 2024: 13.51%

FII holding in Bliss GVS Pharma Ltd has increased recently, indicating rising foreign investor interest.

Bliss GVS Pharma Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 5.78%
• Sept 2025: 5.98%
• Jun 2025: 6.54%
• Mar 2025: 6.55%
• Dec 2024: 6.55%

DII holdings remain stable, reflecting steady institutional participation.

Bliss GVS Pharma Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 44.32%
• Sept 2025: 45.36%
• Jun 2025: 45.36%
• Mar 2025: 44.98%
• Dec 2024: 44.84%

Public holding remains stable with consistent retail participation.

Bliss GVS Pharma Ltd Government Holding

Government holding in Bliss GVS Pharma Ltd currently stands at 0%.

Bliss GVS Pharma Ltd operates without significant government ownership.

Bliss GVS Pharma Ltd Shareholding Analysis Summary

The Bliss GVS Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Bliss GVS Pharma Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Bliss GVS Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.